Phase 3b Findings on Guselkumab Indicate Rapid Scalp Psorias

These data were announced by Johnson & Johnson this week and show several encouraging findings regarding guselkumab’s use among patients of different skin types.

Related Keywords

Hawaii , United States , Guselkumab Tremfya , Andrew Alexis , , Weill Cornell Medicine , Maui Derm Hawaii , Guselkumab Significant , Rapid Scalp Clearance Data , Scalp Specific Investigator Global Assessment , Psoriasis Scalp Severity Index , Scalp Surface Area , Scalp Itch Numeric Rating Scale , Psoriasis Symptoms , Signs Diary , Dermatology Life Quality Index , Guselkumab , Scalp , Psoriasis , People Of Color , Tremfya ,